Progress in Clinical Analysis of Anti-COVID-19 Drugs

XIE Jing; TANG Mingqing; DING Lisheng; LIANG Jian; LI Yi

doi:10.13748/j.cnki.issn1007-7693.2020.06.002

XIE Jing, TANG Mingqing, DING Lisheng, LIANG Jian, LI Yi. Progress in Clinical Analysis of Anti-COVID-19 Drugs[J]. Chinese Journal of Modern Applied Pharmacy, 2020, 37(6): 646-652. DOI: 10.13748/j.cnki.issn1007-7693.2020.06.002

Citation:

Progress in Clinical Analysis of Anti-COVID-19 Drugs

Graphical Abstract

Graphical Abstract

Abstract

Abstract

Lopinavir, ritonavir and ribavirin are recommended in Diagnostic and Treatment Scheme for COVID-19(Trial Version 5). The research progress of clinical drug analysis of lopinavir, ritonavir and ribavirin in recent years is summarized. The focus is on a variety of methods for the determination of drugs in plasma, including HPLC, LC-MS, MS, spectrophotometry, capillary electrophoresis, immunoassay, etc., which provide a reference for the development of therapeutic drug monitoring.

FullText(HTML)

References (39)

Cited By

Turn off MathJax

Article Contents

Progress in Clinical Analysis of Anti-COVID-19 Drugs

Graphical Abstract

Abstract

Catalog

Export File

Citation

Format

Content